The diagnosis and treatment of SARS-CoV-2, the virus responsible for COVID-19, involve a multi-faceted approach informed by evolving scientific understanding. Diagnostic methods include polymerase chain reaction (PCR) tests, antigen tests, and serological tests, which detect the presence of the virus or antibodies in the body. Molecular tests like PCR are considered the gold standard for diagnosing active infections. Treatment for COVID-19 is primarily supportive, addressing symptoms and complications. Severe cases may require hospitalization and interventions such as supplemental oxygen, mechanical ventilation, or extracorporeal membrane oxygenation (ECMO). Antiviral medications like remdesivir may be used in certain cases, and corticosteroids have shown efficacy in reducing mortality for severe cases. Vaccination has emerged as a pivotal tool in preventing severe illness and reducing the spread of the virus. Multiple vaccines, including mRNA vaccines and viral vector vaccines, have demonstrated efficacy in preventing COVID-19 and its complications. Research continues to explore new treatments, refine diagnostic strategies, and address emerging variants. Global efforts focus on vaccination campaigns, public health measures, and ongoing surveillance to manage the impact of the pandemic.
Submit your abstract Today
Title : Tubercular disease in children: Optimizing treatment strategies through disease insights
Elena Chiappini, University of Florence, Italy
Title : Prophylactic and Molecular Approaches for Mitigating Human Influenza A Viruses: i. Evaluating influenza Vaccine Effectiveness in the Older population ii. Down-regulation of influenza virus genes with novel siRNA-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Development of a Novel Multi-component Vaccine to Address the Burden of Otitis Media in High-Risk Populations
Ayesha Zahid, Griffith University, Australia
Title : Targeting resistance: New 4-substituted pyrazolidine and isoxazolidine as antibiotics with interesting antimicrobial activities
Yousfi Tarek, Nationale Research for Biotechnology Research Center, Algeria
Title : Racial disparities in pediatric pneumonia in Brazil: The role of structural racism forging inequalities in acess to vaccines
Livia Daflon Silva, Federal University of State of Rio de Janeiro, Brazil
Title : Immunosuppression in COVID-19 Patients and Emerging Fungal Infections: Vaccines, Diagnosis and Strategies to Treat Comorbidities
K R Aneja, Kurukshetra University, India
Title : Immunogenicity and Cryo-EM structure of native-like HIV-1 Clade-C envelope trimers derived from a pediatric elite-neutralizer
Swarandeep Singh, All India Institute of Medical Sciences, India
Title : Why is the vaccine life-threatening if people get a fever after a COVID-19 vaccination
Yacob Mathai, Marma Health Centre, India
Title : Barriers to polio eradication in South Asia: A systematic review
Awranoos Ahadi, Bolan Medical College, Pakistan